Pasquale Di Carlo

Pasquale Di Carlo

Auto-generated profile, based on publicly available information

Pasquale Di Carlo

Department of Basic Medical Science, Neuroscience and Sense Organs University of Bari, Bari, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
K(Karolinska Schizophrenia Project (KaSP)
Karolinska Schizophrenia Project (KaSP)
TKTobias Kaufmann
Tobias Kaufmann
DMDennis van der Meer
Dennis van der Meer
NDNhat Trung Doan
Nhat Trung Doan
ESEmanuel Schwarz
Emanuel Schwarz
LWLars T. Westlye
Lars T. Westlye

17 January 2017 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
GPG Pergola
G Pergola
PCP Di Carlo
P Di Carlo
EDE D'AMbrosio
E D'AMbrosio
BGB Gelao
B Gelao
LFL Fazio
L Fazio
ABAlessandro Bertolino
Alessandro Bertolino
Genetic risk for schizophrenia (SCZ) is determined by many genetic loci whose compound biological effects are difficult to determine. We hypothesized that co-expression pathways of SCZ risk genes are associated with system-level brain function and clinical phenotypes of SCZ. We examined genetic variants related to the dopamine D2 receptor gene DRD2 co-expression pathway and associated them with working memory (WM) behavior, the related brain activity and treatment response. Using two independent post-mortem prefrontal messenger RNA (mRNA) data sets (total N=249), we identified a DRD2 co-expression pathway enriched for SCZ risk genes. Next, we identified non-coding single-nucleotide polymorphisms (SNPs) associated with co-expression of this pathway. These SNPs were associated with regulatory genetic loci in the dorsolateral prefrontal cortex (P<0.05). We summarized their compound effect on co-expression into a Polygenic Co-expression Index (PCI), which predicted DRD2 pathway co-expression in both mRNA data sets (all P<0.05). We associated the PCI with brain activity during WM performance in two independent samples of healthy individuals (total N=368) and 29 patients with SCZ who performed the n-back task. Greater predicted DRD2 pathway prefrontal co-expression was associated with greater prefrontal activity and longer WM reaction times (all corrected P<0.05), thus indicating inefficient WM processing. Blind prediction of treatment response to antipsychotics in two independent samples of patients with SCZ suggested better clinical course of patientswith greater PCI (total N=87; P<0.05). The findings on this DRD2 co-expression pathway are a proof of concept that gene co-expression can parse SCZ risk genes into biological pathways associated with intermediate phenotypes as well as with clinically meaningful information.

17 January 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
ESEmanuel Schwarz
Emanuel Schwarz
NDNhat Trung Doan
Nhat Trung Doan
GPGiulio Pergola
Giulio Pergola
LWLars T Westlye
Lars T Westlye
TKTobias Kaufmann
Tobias Kaufmann
AMAndreas Meyer-Lindenberg
Andreas Meyer-Lindenberg
Schizophrenia is a severe mental disorder characterized by numerous subtle changes in brain structure and function. Machine learning allows exploring the utility of combining structural and functional brain magnetic resonance imaging (MRI) measures for diagnostic application, but this approach has been hampered by sample size limitations and lack of differential diagnostic data. Here, we performed a multi-site machine learning analysis to explore brain structural patterns of T1 MRI data in 2668 individuals with schizophrenia, bipolar disorder or attention-deficit/ hyperactivity disorder, and healthy controls. We found reproducible changes of structural parameters in schizophrenia that yielded a classification accuracy of up to 76% and provided discrimination from ADHD, through it lacked specificity against bipolar disorder. The observed changes largely indexed distributed grey matter alterations that could be represented through a combination of several global brain-structural parameters. This multi-site machine learning study identified a brain-structural signature that could reproducibly differentiate schizophrenia patients from controls, but lacked specificity against bipolar disorder. While this currently limits the clinical utility of the identified signature, the present study highlights that the underlying alterations index substantial global grey matter changes in psychotic disorders, reflecting the biological similarity of these conditions, and provide a roadmap for future exploration of brain structural alterations in psychiatric patients.

11 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TETorbjørn Elvsåshagen
Torbjørn Elvsåshagen
SBShahram Bahrami
Shahram Bahrami
DMDennis van der Meer
Dennis van der Meer
IAIngrid Agartz
Ingrid Agartz
DADag Alnæs
Dag Alnæs
TKTobias Kaufmann
Tobias Kaufmann
Brainstem regions support vital bodily functions, yet their genetic architectures and involvement in common brain disorders remain understudied. Here, using imaging-genetics data from a discovery sample of 27,034 individuals, we identify 45 brainstem-associated genetic loci, including the first linked to midbrain, pons, and medulla oblongata volumes, and map them to 305 genes. In a replication sample of 7432 participants most of the loci show the same effect direction and are significant at a nominal threshold. We detect genetic overlap between brainstem volumes and eight psychiatric and neurological disorders. In additional clinical data from 5062 individuals with common brain disorders and 11,257 healthy controls, we observe differential volume alterations in schizophrenia, bipolar disorder, multiple sclerosis, mild cognitive impairment, dementia, and Parkinson’s disease, supporting the relevance of brainstem regions and their genetic architectures in common brain disorders.

1 February 2017 in Schizophrenia Research
Verified
Journal Article
Closed access
GPGiulio Pergola
Giulio Pergola
STSilvestro Trizio
Silvestro Trizio
PCPasquale Di Carlo
Pasquale Di Carlo
PTPaolo Taurisano
Paolo Taurisano
MMMarina Mancini
Marina Mancini
GBGiuseppe Blasi
Giuseppe Blasi

1 July 2019 in Biological Psychiatry
Verified
Journal Article
Closed access
GPGiulio Pergola
Giulio Pergola
PCPasquale Di Carlo
Pasquale Di Carlo
AJAndrew E. Jaffe
Andrew E. Jaffe
MPMarco Papalino
Marco Papalino
QCQiang Chen
Qiang Chen
ABAlessandro Bertolino
Alessandro Bertolino